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Abstract  
 
Background: Several mouse lung transplantation (Tx) models have been proposed for the study of 
chronic airway fibrosis (CAF), the most prevalent complication seen in human lung transplant 
recipients, termed chronic lung allograft dysfunction (CLAD). Alternatively, it has been called for 
to establish an experimental animal model for restrictive allograft syndrome (RAS), another 
phenotype of CLAD. However, these mouse transplant models exhibit significant heterogeneity in 
consistency and reproducibility. We therefore aimed at reevaluating current available models. 
Methods: 4 different Tx combinations were employed that manifest CAF: 2 minor 
antigen-mismatched Tx combinations (MINOR, donor: C57BL/10, recipient: C57BL/6J); or 
MINOR-N using recipient C57BL/6N, major histocompatibility antigen-mismatched 
immunosuppressed Tx (MAJOR, donor: BALB/c, recipient: C57BL/6J) and syngeneic Tx (SYN, 
donor and recipient: C57BL/6J) as control. The recipients were harvested and analyzed at week 8. 
Oxygenation, histology, reverse transcription polymerase chain reaction (RT-PCR), and magnetic 
resonance imaging were performed to analyze outcome of those models. Results: The most 
prominent manifestation of CAF, thickest subepithelial fibrotic changes, worst oxygenation and 
the most severe acute rejection were detected in the MAJOR group, compared to all other (p<0.05). 
Gene expressions of TNF-α and TGF-β1 were higher, and IL-10 was lower in the MAJOR group. 
Immunohistochemistry found pleuroparenchymal fibrotic change in both the MAJOR and 
MINOR-J group. Conclusions: We propose the major mismatch model under mild 
immunosuppression as the most suitable model for studying posttransplant CAF, and both the 
major and minor mismatch models for the restrictive phenotype.   
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Introduction 
 
After decades of research, the phenomenon of chronic rejection in lung transplantation, 
clinically identified as chronic lung allograft dysfunction (CLAD), remains the most significant 
hurdle limiting long-term survival after lung transplantation (Tx). [1] CLAD affects 50% of cases 
by 5 years post-Tx, which is higher compared to chronic allograft rejection in other solid organ Tx, 
[1, 2] and the relative risk of death in CLAD patients compared to non-CLAD after lung Tx is 
more than 10 times higher. [3] CLAD comprises bronchiolitis obliterans syndrome (BOS) and/or 
restrictive allograft syndrome (RAS). [4, 5] Bronchiolitis obliterans (BO), a pathological aspect of 
BOS, is characterized by fibrous tissue deposits around and inside small airways, leading to airway 
constriction or obliteration. Alternatively, the histological characteristics of RAS is described as a 
temporal sequence of diffuse alveolar damage, followed by the development of 
pleuroparenchymal fibroelastosis. [4, 6] As chronic airway phenotypes in animal models are not 
identical to pathology of CLAD in clinical lung transplantation, we referred to pathological 
features of BO as „intraluminal chronic airway fibrosis (intra-CAF)‟. Alternatively, pathological 
features of RAS would be regarded as pleuroparenchymal, parenchymal or peribronchiolar 
fibrosis (peri-CAF).  
 
In a light of these clinical issues, a robust and reproducible animal model that mimics the 
human condition is needed to discover effective treatment strategies. The establishment of the 
mouse model of lung Tx has pioneered scientific work due to its physiological nature when 
compared to the human setting, but also due to the availability of genetically engineered animals 
[7-9]. This mouse model has paved the way for the study of transplant-related phenomena and new 
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therapies. [7, 10] Using this model, 2 research groups were the first to propose new models in 
which lesions of airway fibrosis could be induced. [11, 12] The first experimental approach came 
from Fan and colleagues. [11] They employed a minor histocompatibility complex (MHC) 
mismatched mouse strain combination (C57BL/10 → C57BL/6N) to induce mild rejection and 
airway fibrosis that developed over the course of 4 weeks, with an airway obliteration rate of 
44.4%. Shortly thereafter, the Leuven group proposed another approach using a fully MHC 
mismatched strain combination (BALB/c → C57BL/6) while mildly suppressing acute rejection 
with low-dose Cyclosporine and Methylprednisolone. [12] Several studies were done 
subsequently using 1 of these models. [13-15] About RAS development in mice, we could recently 
show that a fully MHC mismatched strain mouse lung Tx combination presented typical 
pathological features of RAS. [16]  
 
We therefore aimed here at reevaluating and comparing the current available models in 
relation to the level of chronic airway fibrosis obtained at long-term and their ability to induce the 
restrictive phenotype. 
 
Materials and Methods 
Mice 
Animals used in this study received care in strict accordance with the Principles of 
Laboratory Animal Care (National Institutes of Health Publication No. 85-23, promulgated in 
1985, most recently revised in 1996). The local Veterinary Ethical Committee approved the study 
(study number 45/2014). Specific pathogen-free inbred male mice weighing 27 to 30 g were used 
for the study. Strain C57BL/6J (H2
b
), C57BL/10J (H-2
b
) and BALB/c (H2
d
) were obtained from 
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Charles River Laboratories (Sulzfeld, Germany). C57BL/6N (H2
b
) was purchased from Harlan 
Laboratories (Venray, The Netherlands).  
 
Transplantation model and experimental groups 
Orthotopic, left single-lung Tx was performed as described previously. [7, 17] The 
following experimental groups were formed (Table 1): (I) syngeneic (SYN) Tx between 
C57BL/6J mice (n=17); (II) Tx between minor mismatched mouse strains, deriving from Charles 
River laboratory (MINOR-J), C57BL/10J serving as donors and C57BL/6J serving as recipients 
(n=10); (III) Tx between minor mismatched mouse strains (MINOR-N), using C57BL/10J as 
donors and C57BL/6N as recipients (n=7); and (IV) Tx between major mismatched mouse strains 
(MAJOR), BALB/c serving as donors and C57BL/6J serving as recipients (n=12). We harvested 
and analyzed the recipients at 8 weeks to compare all the experimental groups, while we 
additionally harvested the samples in the MINOR-J Tx at 4 weeks (n=15) and at 12 weeks (n=7) to 
observe the kinetic change of this protocol. The rationale for testing both C57BL/6J and 
C57BL/6N, both substrains deriving from C57BL/6 and obtained from 2 different providers, is 
2-fold: 1) The genetic drift that has led to disparate spontaneous mutations in C57BL/6J versus 
C57BL/6N mice may influence their susceptibility to airway fibrosis, [18] and 2) the provenance 
of animals may have an impact on phenotype expression due to environmental factors such as 
microbiome composition. [19] In the MAJOR group, daily doses of low-dose 
immunosuppressants were administered subcutaneously, including cyclosporine (10mg/kg/day) 
and methylprednisolone (1.6mg/kg/day), from the day of surgery to the day before harvest, based 
on previous studies. [12, 20]  
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Before graft explantation, arterial blood (200 μl) was aspirated from the descending aorta (without 
clamping the right hilum) for blood gas analysis. We considered mixed blood from the right and 
left lungs to be a reasonable representation of left lung dysfunction and hypoxia.  
 
MRI and Magnetization transfer ratio 
All datasets were acquired using a 4.7T PharmaScan (Bruker, Ettlingen, Germany). Mice 
were anesthetized during the acquisition of the datasets with isoflurane. Magnetization transfer 
ratio (MTR) is an MRI technique that can reveal characteristics of biotissue: The protons in water 
transfer the nuclear spin polarization from 1 population (free water) to another population (water 
"bound" to macromolecules). Using off-resonance radio frequency (RF) pulses, the RF energy is 
applied exclusively to the bound pool resulting in saturation of the macromolecular spins. Some of 
the spin saturation is then transferred to the free water pool. Thus, the free water pool becomes 
partially saturated leading to a reduction in the MRI signal compared to the acquisition without 
off-resonance pulse. This ratio between the signal reduction and the nonsaturated signal is called 
the Magnetization Transfer Ratio MTR=(M0-Msat)/M0. As magnetization transfer results in a 
reduction of the MRI signal, it is crucial that a MRI sequence is used which provides signal above 
the noise level, otherwise the reduction would not be measurable. Obtaining an MRI signal from 
lung tissue is nontrivial due to the ultrafast signal decay, which is caused by microscopic magnetic 
field inhomogeneities at tissue-air interfaces. We applied a zero echo-time sequence (ZTE) with 
radial k-space readout capable to detect lung signal. The ZTE sequence was equipped with an 
off-resonance prepulse with adaptable off-resonance frequency and flip angle.  After acquisition 
of the data with nominal prepulse flip angle of 1000 or 3000° and off-resonance frequencies of 
1000, 2000, 3000, 4000, 6000, 8000, 10000 and 15000Hz, MTR values were calculated and 
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compared, and MTR maps were depicted with in-house computer programs. [21, 22] 
 
Histology and Immunhistochemistry 
Tx lungs from each group were fixed in 4% phosphate-buffered formalin, cut, and 
embedded in paraffin. Sections of 4-μm thickness were cut and stained with hematoxylin and eosin 
(HE) stain, Masson's Trichrome stain and Elastica van Gieson stain. For the histological evaluation, 
the pathological severity of acute rejection (AR) and CAF were assessed by 3 different 
investigators. AR grading (A-grade) was based on the guidelines of the international society for 
heart and lung transplantation (ISHLT). [23] We defined chronic airway fibrosis (CAF) as 
eosinophilic hyaline fibrosis in the submucosa of membranous and respiratory bronchioles 
(peri-CAF) or intraluminal fibrosis of the airways (intra-CAF). [23] We evaluated each graft for 
the presence of absence of any airways obliterated (completely or partially) with intraluminal 
fibrosis. In addition, we scored the degree of fibrotic changes in peri-CAF, intra-CAF and 
pleuroparenchymal fibrosis, grading on a general scale of 0-4.  
 
For morphometric analysis, we applied a quantitative assessment of airway wall thickness 
so that only peribronchiolar fibrotic lesions could be objectively evaluated. The volume fraction of 
subepithelial connective tissue was measured from the basement membrane to the outer edge of 
the airway adventitia (Vvsub) by the public domain image processing program ImageJ. Airway wall 
thickness was calculated by dividing Vvsub by the length of the subepithelial basement membrane. 
[15, 24, 25] We randomly chose 5 bronchioles with distinguishable structure and the diameter of 
150 μm in each left graft. 
Immunohistochemistry was performed as previously described. [17] Primary antibodies 
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were mouse anti smooth muscle actin (αSMA) mAb (1A4, Dako Denmark A/S, Glostrup, 
Denmark) and rabbit anti vimentin mAb (D21H3, BioConcept, Allschwil, Switzerland), rabbit 
anti-CD3 mAb (RMAB005, Diagnostic Biosystems, Pleasanton, CA), rat anti F4/80 mAb (T-1006, 
BMA Biomedicals, Augst, Switzerland), rat anti B220 mAb (RA3-6B2, BD Biosciences Europe, 
Allschwil, Switzerland) and goat anti NKp46 Ab (NCR1, BD Biosciences Europe, Allschwil, 
Switzerland). Mouse spleen was used for positive control with the primary antibodies, while 
samples without primary antibody served as negative control. We assessed each sample grading on 
a general scale of 0-4.  
 
Quantitative real-time PCR  
Total RNA was extracted by mirVana Paris kit (Ambion, Thermo Fisher Scientific, 
Waltham, MA) following the manufacturer's instructions. Five micrograms of RNA were used for 
reverse transcription by ThermoScript reverse transcription polymerase chain reaction (RT-PCR) 
System (Invitrogen, Thermo Fisher Scientific) yielding cDNA template. Quantitative real-time 
PCR amplification and data analysis were performed using 7500 Fast Real-Time PCR System 
(Applied Biosystems, Thermo Fisher Scientific). Taq Man gene expression assays were used to 
quantify mRNA expression of the respective genes. mRNA expression levels of each sample were 
normalized to 18S RNA (Taq Man rRNA control reagents; Applied Biosystems, Thermo Fisher 
Scientific). All mRNA expression data was calculated as fold change from naïve animal tissues. 
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Statistics  
Histological evaluations as ordinal variables were depicted in scatter plots, showing the 
median value. In comparisons of ordinal variables among the groups, Kruskal-Wallis test was 
used; in continuous variables, analysis of variance with a post hoc Tukey test was performed; and 
in categorical variables Fischer‟s exact test with Bonferroni‟s correction was applied to determine 
differences. A 2-sided p value < 0.05 was considered statistically significant. Prism 5 (GraphPad 
Software Inc., La Jolla, CA) was used for the statistical calculations. 
  
Results 
Development of airway fibrotic lesions varied between models  
Control syngeneic transplants showed neither lymphocytic infiltration nor fibrotic changes 
(Figure 1A, B, Figure 2A, B). Transplanted lungs in the MINOR-J group showed moderate 
perivascular and peribronchiolar inflammation with periairway fibrosis (Figure 1C, D; Figure 2C, 
D). Grafts in the MINOR-N group showed the same degree of inflammation as the MINOR-J 
(Figure 1E, F; Figure 2E, F). In contrast, allografts in the MAJOR group presented severe 
lymphocytic infiltration in perivascular and peribronchiolar areas, mostly graded as A4 (Figure 1G, 
H), paralleled by accumulation of fibrotic tissue around and inside airways, as well as the 
parenchyma (Figure 2G, H). The evaluation of the pathological score of AR based on the ISHLT 
guidelines [23] revealed that MAJOR had distribution with higher AR scores compared to other 
groups (Figure 1G, H; Figure 3) (p<0.05). AR scores between MINOR-J and MINOR-N were 
comparable (Figure 1. C-F; Figure 3). SYN showed relatively lower AR scores than others, 
although there were no significant differences (Figure 1A, B; Figure 3).  
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Table 1 gives the overview of intra-CAF in all samples. Ten out of 12 (83%) of grafts in 
MAJOR showed obliterated airway, while none in either MINOR-J or MINOR-N at every time 
point, yielding statistical significant differences between MAJOR and others (p<0.0033 with 
Bonferroni‟s correction). Likewise, the scoring evaluation with 8-week graft for intra-CAF 
showed the significant differences between MAJOR and others by Kruskal-Wallis test (p<0.05) 
(Figure 4A). About peri-CAF, both MAJOR and MINOR-J showed distributions with higher 
fibrotic change score, compared to SYN (p<0.05). MAJOR also presented significant difference 
compared to MINOR-N (Figure 4B). We also examined pleural and parenchymal fibrotic changes 
in the same manner for CAF evaluation. In pleural evaluation, MINOR-J and MAJOR showed 
comparable fibrotic degrees, but both were higher than the SYN (Figure S1A, SDC, 
http://links.lww.com/TP/B474). In parenchymal fibrosis, the MAJOR group showed relatively 
higher than MINOR-J, although no significant difference (Figure S1B, SDC, 
http://links.lww.com/TP/B474).  
 
We also examined immunohistochemistry on 8 week grafts to elucidate what kind of cells 
were involved. In the evaluation of extra cellular matrix, MAJOR showed significantly higher 
grades in αSMA than other groups (Figure 5A, C, E, G, Figure 6). Also in vimentin, MAJOR had 
higher scores than SYN and MINOR-J. The intensity of immune cells such as T cells, B cells, 
macrophages and NK cells were comparable between MINOR-J and MAJOR, while SYN 
presented the lower intensity on that immunohistochemistry compared to the 2 groups. (Figure S2, 
S3, SDC, http://links.lww.com/TP/B474).  
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Morphometric analysis detected prominent peri-CAF in the MAJOR group  
A morphometric analysis of grafts was performed to calculate the airway wall thickness for 
an objective evaluation of peribronchiolar fibrosis. MAJOR showed significantly thickest airway 
walls of all, while SYN showed thinnest airway walls (Figure 7, p<0.05). 
 
Decreased oxygenation in immunosuppressed major mismatch mice (MAJOR group)  
For the investigation of the functionality of transplant lungs, blood gas analysis was 
performed. 200 µl of arterial blood was withdrawn at the 8
th
 week from the abdominal aorta of 
recipients. The MAJOR group presented significantly lower levels of PaO2/FiO2 than others 
(p<0.05) (Figure 8). 
 
TNF-α and TGF-β1 were elevated in MAJOR 
We analyzed levels of inflammatory and antiinflammatory cytokines within recipient 
transplants in the grafts of the MINOR-J group and the MAJOR group by RT-PCR (Figure 9). 
Gene expression levels of the Th1 cytokine TNF-α was significantly elevated in the MAJOR group 
compared to the MINOR, while levels of the Th2 cytokine IL-10 was lower than the MINOR 
group. Additionally, levels of TGF-β1, which plays a pivotal role in the development of fibrosis, 
were elevated in the MAJOR group. 
 
MR imaging detects CAF 
We next evaluated whether a novel MR imaging technology has the potential for the 
detection and evaluation of the extension of CAF. Typical examples are provided in Figure 10. In 
overall, MTR values on left grafts was higher than naïve right lungs, while infiltrated lung without 
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CAF exhibited higher MTR values compared to infiltrated lungs with CAF for all frequencies and 
flip angles (data not shown).  
 
Discussion 
In this study, we reevaluated the currently available mouse lung transplant models of CAF. 
We combined different strains and protocols in order to identify the most consistent model. We 
found that the combination of major mismatched Tx (MAJOR) revealed the highest rate of 
intraluminal airway fibrosis, which developed in 83% of grafts 8 weeks after lung Tx, and the most 
severe periairway fibrosis. Additionally, both the minor and major mismatched Tx presented 
pathological features of RAS phenotype. 
 
The finding that a minor mismatched strain combination develops CAF has been a 
pioneering finding by Fan, Wilkes and colleagues. [11] This Tx combination induces a low-grade 
but continued development of allograft rejection with a mild degree of immune cell infiltration 
over time which does not completely damage the transplanted graft as it is known from the major 
BALB/c → C57BL/6 combination. [17] Several groups have used this minor mismatched strain 
model in their studies. [13-15] The development of airway obliteration in these studies was 
between 0% and 44%, at 3 to 4 weeks after Tx. [14] The exact cause of such variability in this 
model remains unclear. In our hands, however, using the similar mouse strains with C57BL/6J did 
not show any airway obliteration. This variation may be due to strain variability and environmental 
factors between substrains and animal providers. [14] The use of 2 different providers in prior 
studies, namely C57BL/6N and C57BL/6J, prompted us to include the C57BL/6N for testing of 
this hypothesis. However, this strain did not develop airway obliteration either. Alternatively, 
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Chang et al, showed that allografts with warm ischemia in a minor mismatch combination in rat 
lung transplant presented higher ratio of occluded airway compared to allografts only with cold 
ischemia. [26] Likewise, Watanabe et al, presented that the minor combination only with cold 
ischemia did not develop BO pathology at all, but some allografts in this combination added with 
warm ischemia. [27] In order to induce chronic airway fibrosis in the minor combination, a certain 
degree of damage such as warm ischemia might be necessary. Along with this context, a report 
from Mimura et al, is of higher interest: employing a B6D2F1/J strain (a cross breeding between 
C57BL/6J and DBA/2J, H2b/d) for the donor and a DBA/2J strain (H2d) for the recipient, the 
development ratio of airway obliteration was 100%. [15] This showed another evidence that 
allodifference of the minor combination was just not enough to induce chronic airway fibrosis. To 
rule out that allografts of the minor combination developed obliteration changes, we monitored 
them by harvesting on 4 weeks, 8 weeks and 12 However, there was no morphological change.  
 
In human lung transplantation, allorecognition and MHC mismatching may not fully 
account for development of CAF lesions. Many factors are thought to play a role in a complex 
clinical setting. Nonimmunological injuries such as viral or bacterial infections, primary graft 
dysfunction (innate immunity) and acid aspiration by the patient contribute to the complex picture 
of CLAD and obliterative bronchiolitis. Also, self-antigens seem to play a role in the genesis of 
CLAD. In this context, the group from Mohanakumar and colleagues introduced a model where 
mice were given intratracheal administrations of antibodies against self-antigens such as type V 
Collagen (Col-V) or K-alpha-1-tubulin, which already have shown to play important roles in acute 
or chronic rejection [28]. However, although this model revealed 80% lesions of peri-CAF, the 
lack of an actual lung transplant makes it a little more different from the clinical scenario. 
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In our studies, we have shown a higher prevalence and severity of CAF in the fully major 
histocompatibility complex mismatched combination with low-dose immunosuppression [12]. 
The 2 advantages of this model are that this protocol simulates the clinical setting of 
allotransplantation across a major MHC mismatch with the induction of AR, and the concomitant 
application of immunosuppression. The mechanism of CAF development in this model seems to 
be more complex and multifactorial as it is found in human Tx. Indeed, when reproducing this 
protocol, it resulted in 83% of the development of airway obliterate lesions 8 weeks after Tx. On 
the other hand, as a disadvantage, this protocol takes longer to generate the fully developed 
obliterated airway lesions. Although in our hands, the MAJOR group confirmed to be the most 
reliable and consistent model of CAF, the logistic effort to develop lesions is quite high in terms of 
long-term daily administration of immunosuppressant. 
 
Both MINOR-J and MINOR-N showed thicker airway walls and higher peri-CAF scores 
compared to SYN. Moreover, the evaluation for pleural fibrosis presented comparable fibrotic 
scores among MINOR-J, MINOR-N and MAJOR, all significantly higher than SYN. These 
pathological findings were suggestive for RAS development [3, 4, 6] We reported before that the 
MAJOR combination using immunosuppression revealed RAS pathology. [16] The current study 
showed that not only the major mismatched combination but also the minor combination might 
present pathological features of RAS, suggesting these protocols as experimental models to 
investigate RAS phenotype of CLAD. Indeed, some experimental studies already employed 
peribronchial fibrosis as an end-point to discuss CLAD. [28-30]  
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Cytokine analyses reflected the development of CAF among the experimental groups. 
Recent evidence suggests that Th1 and Th17 influence CLAD after lung transplantation. [31] 
While TGF-β is essential in Th17 differentiation, this cytokine itself also plays a pivotal role in the 
development of fibrosis. [32] Our cytokine analyses corroborate previous findings showing that 
the MAJOR group had prominent CAF with elevated gene levels of Th1 cytokines and TGF-β1. 
We furthermore observed comparable expressions of T cells, B cells, macrophages and NK cells 
between the Minor and the Major combination, although those phenotypes are relevant during 
CLAD development. [14, 33-36] Antigens of the extracellular matrix such as vimentin, Col V and 
K-alpha-1-tubulin are key factors for CLAD development. [37, 38] We speculated that these 
factors could be the most decisive for BO phenotype of CLAD.  
 
We previously suggest MR imaging for the detection of acute rejection. [39] Higher 
protein content in the infiltrated lung tissue leading to significantly higher magnetization transfer 
due to the interaction of macromolecular spin pool with the water spin pool is thought to be the 
mechanisms behind. We here could observe differences of MTR values between allograft with and 
without CAF. This was prosumably due to interaction of collagen and the “free-water-protons”, 
particularly when sufficiently high off-resonance frequencies were chosen in order to preclude 
relevant direct saturation effects. We believe from these data that MRI could be a putative tool to 
detect CAF after lung transplantation.  
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Taken together, among the most recent and relevant experimental CLAD models proposed, 
the major histocompatibility mismatched combination treated by low-dose immunosuppression 
seems to be the most consistent model with highest yields of CAF in our hands. This model reflects 
most closely the clinical situation thus making it an appealing tool for finding new therapeutics 
against CLAD in lung Tx. However, for an even more complete model, viral and bacterial 
infections as well as nonimmunological injuries to the transplant could be added to make a CLAD 
model even more relevant for a transfer of findings and knowledge into clinical application.  
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Figure legends 
 
Figure 1: Representative H&E histology of lung grafts on the 8th week in lower magnification 
(25x: A, C, E, G) and higher magnification (100x: B, D, F, H). Grafts of a syngeneic combination 
(SYN) showed no lymphocytic infiltration (A0) (A, B). Grafts of minor histocompatibility antigen 
mismatched combination with C57BL/6J (MINOR-J) showed moderate infiltration (C, D) as well 
as the MINOR-N with C57BL/6N (E, F). Grafts of major histocompatibility antigen mismatched 
combination (MAJOR) had severe lymphocytic infiltration and intraluminal fibrotic changes with 
airway obliteration (G, H). Scale bars indicates 500 µm on A, C, E and G, and 200 µm on B, D, F 
and H. MAJOR; major histocompatibility antigen mismatched combination, MINOR; minor 
histocompatibility antigen mismatched combination, SYN; syngeneic combination. 
 
Figure 2: Representative Trichrome staining histology of lung grafts corresponding to Figure 1 
(25x: A, C, E, G; 100x: B, D, F, H). Grafts of the SYN group showed no fibrosis (A, B). Grafts of 
MINOR-J and -N presented mild fibrotic changes in peribronchiolar areas (C, D, E, F). Grafts of 
MAJOR showed not only peribronchiolar fibrosis but also intraluminal fibrotic airway obliteration 
(G, H). Scale bars indicates 500 µm on A, C, E and G, and 200 µm on B, D, F and H. MAJOR; 
major histocompatibility antigen mismatched combination, MINOR; minor histocompatibility 
antigen mismatched combination, MT; Masson‟s Trichrome staining, SYN; syngeneic 
combination. 
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Figure 3: Scatter plots of acute rejection scores of 8 week grafts based on the ISHLT guidelines. 
AR scores of the MAJOR group were distributed in higher grades, and Kruskal-Wallis test 
detected significant differences in comparisons of MAJOR to SYN, MINOR-J or MINOR-N 
(p<0.05). Bars indicate medians of values. An asterisk indicates significant difference. MAJOR; 
major histocompatibility antigen mismatched combination, MINOR; minor antigen mismatched 
combination, SYN; syngeneic combination. 
 
Figure 4: Scatter plots of fibrotic evaluation of 8 week grafts in intraluminal area (intra-CAF) and 
peribronchiolar areas (peri-CAF) graded with 0-4 score.  (A) Only the MAJOR group had 
allografts (10/12) with intra-CAF distributing from score 1 to 3, instead other groups have none. 
Kruskal-Wallis test detected significant differences between MARJOR and others (p<0.05). (B) 
Both MAJOR and MINOR-J showed distributions with higher fibrotic change score in peri-CAF, 
compared to SYN (p<0.05). MAJOR also presented significant difference compared to MINOR-N. 
Bars indicate median of values. Asterisks indicate significant difference. CAF; chronic airway 
fibrosis, MAJOR; major histocompatibility antigen mismatched combination, MINOR; minor 
histocompatibility antigen mismatched combination, SYN; syngeneic combination. 
 
Figure 5: Representative immunohistochemistry for αSMA (25x: A, C, E, G) and Vimentin (25x: 
B, D, G, H) of 8 week grafts. The MAJOR group showed higher intensity of the positive cells on 
each staining than others. Scale bars indicates 500 µm. MAJOR; major histocompatibility antigen 
mismatched combination, MINOR; minor histocompatibility antigen mismatched combination, 
SYN; syngeneic combination. 
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Figure 6: The intensity of positive cells in αSMA and Vimentin immunohistochemistry (Figure 1) 
graded with 0-4 scores. (A) The MAJOR group presented distribution with higher scores in αSMA 
immunohistochemistry, showing significant differences compared to other groups (p<0.05). (B) 
MAJOR presented distribution with higher scores in Vimentin immunohistochemistry, yielding 
significant differences compared to SYN or MINOR-J (p<0.05). Bars indicate medians of values. 
Asterisks indicate significant differences. MAJOR; major histocompatibility antigen mismatched 
combination, MINOR; minor histocompatibility antigen mismatched combination, SYN; 
syngeneic combination. 
 
Figure 7: Peribronchiolar airway wall thickness. Airway thickness was compared among groups. 
MAJOR showed significantly thickest airway walls of all (‡, p<0.05); while SYN was the thinnest 
of all (†, p<0.05). Error bars show standard deviations. MAJOR; major histocompatibility antigen 
mismatched combination, MINOR; minor histocompatibility antigen mismatched combination, 
SYN; syngeneic combination. 
 
Figure 8: Blood gas analysis on week 8. PaO2/FiO2 ratios in the MAJOR group were significantly 
lowest (p<0.05). The asterisk indicates the significant differences compared to other groups. Error 
bars show standard deviations. MAJOR; major histocompatibility antigen mismatched 
combination, MINOR; minor histocompatibility antigen mismatched combination, SYN; 
syngeneic combination. 
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Figure 9: Cytokine analyses by RT-PCR. MAJOR presented higher levels of TNF-α (A) and 
TGF- β1 (C) and lower levels of IL-10 (B), compared to MINOR-J. Error bars show standard 
deviations. Asterisks indicate significant differences. MAJOR; major histocompatibility antigen 
mismatched combination, MINOR; minor histocompatibility antigen mismatched combination; 
RT-PCR; reverse transcription polymerase chain reaction. 
 
Figure 10: MRI images and MTR maps. Recipient mice with and without CAF on the 8th week 
were examined by MRI depicting ananatomical map (A, C) and magnetizing transfer ratio (MTR) 
map with a flip angle of 1000° and an off-resonance frequency of 3000 Hz (B, D). The dotted areas 
indicate transplanted grafts. In each group, the MTR intensity on the left graft was higher than the 
naïve right lung. On the other hand, the MTR intensity on the graft in „CAF (-)‟ was higher than 
„CAF (+)‟. CAF; chronic airway fibrosis, MTR; magnetizing transfer ratio 
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Figure 2 
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Figure 3 
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Figure 4 
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Figure 5 
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Figure 6 
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Figure 7 
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Figure 8 
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Figure 9 
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Figure 10 
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Table 1: List of the experimental groups and the development of intra-CAF 
Experimental group SYN MINOR-J MINOR-N MAJOR 
Donor C57BL/6J  C57BL/10J C57BL/10J BALB/c 
Recipient C57BL/6J C57BL/6J C57BL/6N C57BL/6J 
Immunosuppressant No No No Yes 
intra-CAF/ Total mice (%)     
  4 weeks after Tx - 0/ 15 (0) * - - 
 8 weeks after Tx 0/17 (0) * 0/ 10 (0) * 0/ 7 (0) * 10/12 (83.3) 
 12 weeks after Tx - 0/ 7 (0) * - - 
 
* Significant difference compared with the MAJOR group harvested on the 8
th
 week (p<0.05). 
intra-CAF; intraluminal chronic airway fibrosis, MAJOR; major histocompatibility antigen 
mismatched combination, MINNOR; minor histocompatibility antigen mismatched combination, 
SYN; syngeneic combination, Tx; transplantation 
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Supplemental Figure 1: Evaluation for pleural and parenchymal fibrosis. Fibrotic 
changes in pleura or parenchyma of grafts on week 8 were graded with 0-4 score. (A) 
MINOR-J, MINOR-N and MAJOR showed comparable pleural fibrotic changes, which 
presented distributions with higher grades compared to SYN. (B) In parenchymal fibrosis, 
differences between SYN and MAJOR were observed. Bars indicate medians of values. 
Asterisks indicate significant differences. MAJOR; major histocompatibility antigen 
mismatched combination, MINOR; minor histocompatibility antigen mismatched 
combination, SYN; syngeneic combination. 
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Supplemental Figure 2: Representative immunohistochemistry of CD3 (T cell, 25x: A, E, 
I), B220 (B cell: 25x: B, F, J), F4/80 (macrophage: 100x: C, G, K) and NKp46 (NK cell: 
100x: D, H, L) of 8 week grafts. Scale bars indicates either 500 µm (A, B, E, F, I, J) or 200 
µm (C, D, G, H, K, L). MAJOR; major histocompatibility antigen mismatched combination, 
MINOR; minor histocompatibility antigen mismatched combination, SYN; syngeneic 
combination. 
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Supplemental Figure 3: Analyses of the intensity of positive cells in the 
immunohistochemistry on the supplemental Figure 2. Both MINOR-J and MAJOR 
presented distributions of CD3 (A), B220 (B) and F4/80 (C) with higher intensity 
compared to SYN (p<0.05). The intensities in NKp46 were comparable among the groups. 
Bars indicate medians of values. Asterisks indicate significant differences. MAJOR; major 
histocompatibility antigen mismatched combination, MINOR; minor histocompatibility 
antigen mismatched combination, SYN; syngeneic combination. 
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